Lilly Bests Novo Again, Rare Disease Week Goes Regulatory, More CDC Leadership Upheaval on February 25, 2026 CagriSema Centers for Disease Control and Prevention (U.S.) disease therapies eli lilly Infrequent Leadership mechanism pathway Precision Medicine United States Food and Drug Administration Zepbound +